Technology area: Communications
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Therapanacea currently has 1 pending office action in the Communications technology area. This single active filing represents the current focus of the company's patent prosecution efforts within the telecommunications sector and indicates a highly concentrated intellectual property interest.
The matter is being reviewed by a distinct examiner within 1 distinct art unit. This centralized review process means that the company's success in the Communications area is currently tied to a single administrative path and a single technical evaluator, which can lead to more predictable prosecution timelines.
ZAK, JACQUELINE ROSE is the busiest examiner for the portfolio, managing 1 pending office action. As the sole examiner involved, their specific interpretation of patent law and technical standards will be the primary influence on the company's immediate intellectual property outcomes. Practitioners should focus on the specific precedents set within this art unit to navigate the current prosecution successfully.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZAK, JACQUELINE ROSE | 1 | 63.2% | +17.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18925477 | DEVICE AND METHOD FOR DETECTING AND SEGMENTING AT LEAST ONE REGION OF INTEREST IN A 3D IMAGE | ZAK, JACQUELINE ROSE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18925477 | DEVICE AND METHOD FOR DETECTING AND SEGMENTING AT LEAST ONE REGION OF INTEREST IN A 3D IMAGE | ZAK, JACQUELINE ROSE | — |
| Art Unit | Apps |
|---|---|
| 2666 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18925477 | DEVICE AND METHOD FOR DETECTING AND SEGMENTING AT LEAST ONE REGION OF INTEREST IN A 3D IMAGE | ZAK, JACQUELINE ROSE | 2666 | §101§103 | Non-Final OA | — | Pending | Oct 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTherapanacea has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jacqueline Rose Zak has the most, with 1 of Therapanacea's pending office actions.
Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.
